Which companies overlap with Lanzhou Institute of Biological Products Co., Ltd's portfolio?

Top competitors by shared drug class: Ivo Pitanguy Institute, Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust, University of Utah.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/lanzhou-institute-of-biological-products-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Lanzhou Institute of Biological Products Co., Ltd — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Lanzhou Institute of Biological Products Co., Ltd pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Botulinum Toxin Type A for Injection	Botulinum Toxin Type A for Injection	phase 3	Neurotoxin; neuromuscular blocking agent	SNAP-25 (synaptosome-associated protein of 25 kDa); acetylcholine release machinery	Neurology; Dermatology; Aesthetics

Therapeutic area mix

Neurology; Dermatology; Aesthetics · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Ivo Pitanguy Institute · 1 shared drug class
Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust · 1 shared drug class
University of Utah · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Lanzhou Institute of Biological Products Co., Ltd:

Cite this brief

Drug Landscape (2026). Lanzhou Institute of Biological Products Co., Ltd — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/lanzhou-institute-of-biological-products-co-ltd. Accessed 2026-05-17.